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Background. Sapovirus is one of the primary viral causes of acute gastroenteritis (AGE), especially where rotavirus vaccination 
has been implemented. The characteristics and impact of natural infection at the community level, however, have not been well 
documented.
Methods. Stool samples were analyzed from 100 children randomly selected from a community-based birth cohort study in 
Peru. All diarrheal and 1 nondiarrheal stools collected trimonthly from children up to age 2 years (n = 1669) were tested for sapo-
virus detection. Viral shedding duration was determined by testing additional weekly samples (n = 440) collected before and after a 
sapovirus-positive sample.
Results. The incidence of sapovirus infection in the first and second years of life was 4.3 and 11.1 per 100 child-months, respec-
tively. By age 2 years, 82% of children had at least 1 sapovirus infection, and 64% had at least 1 sapovirus-associated diarrhea episode. 
The median shedding period was 18.5 days. In 112 of 175 infections, 14 genotypes from 4 genogroups (GI, GII, GIV, and GV) were 
determined. Among genogroups, GI were more frequently found in symptomatic infections than in asymptomatic infections (odds 
ratio, 3.1; 95% confidence interval, 1.3–7.4). Fifty-nine children had serial sapovirus infections, but only 3 had repeated infection of 
the same genotype.
Conclusions. Sapovirus was frequently detected in children with AGE at the community level during the first 2 years of life. 
Serial sapovirus infections by multiple genotypes in a child suggest genotype-specific immunity from each infection, which needs to 
be taken into account for vaccine development.
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 Diarrhea is the second leading cause of child mortality world-
wide, causing an estimated 800,000 deaths annually [1]. Rotavirus 
was the major cause of severe diarrhea in infants prior to the 
introduction of vaccination programs [2]. Today, in countries 
where rotavirus vaccination coverage is high, norovirus, sapovi-
rus, adenovirus, and astrovirus have emerged as the most impor-
tant causes of viral gastroenteritis [3, 4]. In a community-based 
study in Nicaragua, after norovirus, sapovirus was identified as 
the second most frequent cause of acute gastroenteritis (AGE) 
in children, following norovirus but more frequent than rotavi-
rus [3]. A similar pattern was also observed among children in a 
Peruvian hospital (unpublished data, S.B. Ballard).
Sapovirus, a member of the Caliciviridae family, is a sin-
gle-stranded positive sense RNA virus [5] with 4 genogroups, 
GI, GII, GIV, and GV, that infect humans [6–8]. Sapovirus infec-
tions primarily affect children aged <5  years, causing mild to 
moderate diarrhea [9, 10] and outbreaks in all age groups [11–
14]. Though research on sapovirus outbreaks [15–17] and hos-
pital-based case-control studies [18–20] have been carried out, 
only a few community-based studies with active surveillance 
have examined the natural history of sapovirus. These include 
a study in the Netherlands that detected 5%–9% of sapovirus 
in children with gastroenteritis aged 0.5–11 months [9] and a 
study in Brazil that detected 3% in children with gastroenteritis 
aged <5 years by conventional reverse transcription polymerase 
chain reaction (RT–PCR) [21]. Using RT real-time quantitative 
PCR (RT-qPCR), the study in Nicaragua reported that 17% of 
children aged<5 years with AGE had sapovirus infection [3].
We previously reported significant attribution of sapovirus to 
AGE in a case-control study [22] using selected stool samples 
collected from a Peruvian birth cohort [23]. Based on the those 
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results, we randomly selected 100 children from the same cohort 
to determine the following: prevalence of sapovirus in diarrheal 
and nondiarrheal samples, incidence of sapovirus infection and 
reinfection during the first 2 years of life, genogroup and gen-
otype distribution, and duration of viral shedding. Elucidating 
these epidemiological parameters at the community level is key 
to the development of effective control strategies, including vac-
cine development.
METHODS
Sample Selection for Sapovirus Infection
In a previous cohort study conducted from June 2007 to April 
2011, 291 children were followed from birth until age 2 years 
for norovirus infection [23]. For this sapovirus study, we ran-
domly selected 100 children from the norovirus cohort study 
who completed 2  years of follow-up and analyzed archived 
stool samples. The stool samples tested were diarrheal samples 
collected during each episode of diarrhea (n = 877) and non-
diarrheal samples (n  =  792) collected every 3  months. These 
nondiarrheal stools were chosen systematically from archived 
weekly collected stools; 8 samples were missing. Samples were 
selected independently regardless of previous norovirus and 
sapovirus results from the same cohort [22, 23]. However, 709 
samples for the present study overlapped with samples tested in 
the norovirus cohort study, from which 476 were diarrhea stool 
samples [23]. Also, 205 stool samples overlapped with the sam-
ples tested in the previous case-control study [22].
All samples (n = 1669) were collected prior to addition of the 
rotavirus vaccine Rotarix to Peru’s national vaccine schedule.
Definitions
A day of diarrhea was defined by the presence of ≥3 liquid or 
semiliquid stools in 24 hours. For infants aged <2 months, the 
definition also required that the mother or caregiver considered 
the child to have diarrhea. The start date for a symptomatic 
infection was defined by the first day with diarrhea [23]. An 
episode of diarrhea was considered complete when the infant 
had 2 consecutive days without diarrhea [23].
A sample was considered positive for sapovirus and an infec-
tion was defined if the sample was positive by RT-qPCR. If a 
positive sample was detected later in the same child, it was con-
sidered a new infection if 1 of the following conditions applied: 
identification of a new sapovirus genotype in a participant’s 
sample at any time; sapovirus with at least 2 intervening neg-
ative samples unless the same genotype was detected within 
30 days; or, if only 1 negative sample existed, a 30-day interval 
was required to define a new sapovirus infection.
A “sapovirus symptomatic infection” was defined as a 
positive RT-qPCR result in a stool taken during or within 
7 days of the beginning or end of the diarrheal episode. An 
“asymptomatic” infection occurred when no symptoms were 
reported within 7 days of the positive specimen. “Undefined” 
infection occurred when sapovirus was detected in a stool 
specimen more than 7 days before or after diarrhea onset but 
less than 14 days.
Duration of Viral Shedding
Shedding was evaluated for a subset of the infections detected 
in the cohort testing described above. Eligible infections 
were those for which genotyping was successful and at least 2 
weekly specimens were available before and after sapovirus was 
detected in a stool sample. The weekly samples tested in add-
ition to the cohort samples described above are referred to as 
“shedding samples” (n  =  440). The beginning and end of the 
shedding period were defined based on 2 consecutive negative 
results, as described elsewhere [23]. Positive shedding samples 
were sequenced to confirm that they belonged to the same 
infection by the same genotype if the samples are taken more 
than 7 days apart.
Reverse Transcription and qPCR for Sapovirus Detection
Archived stool samples, stored at −80°C, were allowed to thaw 
at 4°C. A 10% stool suspension was prepared and centrifuged 
at 5000  × g for 10 minutes. Viral RNA was extracted using 
140 μL of the supernatant using the QIAamp viral RNA kit and 
the QIAcube (Qiagen, Hilden, Germany). The complementary 
DNA (cDNA) was synthesized using the SuperScript III First-
Strand Synthesis System with random primers, according to the 
manufacturer’s protocol (Invitrogen, Carlsbad, California).
The RT-qPCR targeting the sapovirus polymerase-viral pro-
tein 1 (VP1) junction, using previously described primers and 
probes [24], was carried out using the LightCycler 96 thermocy-
cler (Roche, Germany). The RT-qPCR reaction was performed 
in a final volume of 10 uL, containing 1 uL of cDNA, 1X of 
TaqMan Fast Advanced Master Mix (Life Technologies, Foster 
City, California), 10 pmol of each primer (Sapovirus124F, 
Sapovirus1F, Sapovirus5F, and Sapovirus1245R), and 10 pmol of 
each probe (Sapovirus124TP and Sapovirus5TP). Amplification 
conditions were 50°C for 2 minutes, 95°C for 15 minutes, 45 
cycles each consisting of 95°C for 30 seconds and 60°C for 30 
seconds, and finally 60°C for 2 minutes.
The detection limit was determined using a standard curve 
based on a 10-fold serial dilution (107–101) of GII.4 plasmid 
provided by the Department of Virology, Tohoku University 
(Sendai, Japan). The detection limit was 10 copies correspond-
ing to a cycle of quantification (Cq) of 38.0. A sample with a 
Cq value ≤38.0 and a sigmoidal amplification curve in the 
RT-qPCR was considered positive. Samples with Cq values 
>38.0 and <40.0 were considered positive if conventional PCR 
for genotyping was positive and its genotype was identified.
Norovirus and Rotavirus Detection by qPCR
 Sapovirus diarrheal samples were tested to determine the 
proportion of coinfection with norovirus and rotavirus using 
methods described previously [23, 25].
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Genotyping and Sequence Analysis
In this study, the partial capsid region was used for genotyping. 
All sapovirus-positive samples by RT-qPCR were amplified by 
a nested PCR targeting a partial sequence of the VP1 gene (400 
nucleotides). The first PCR reaction was performed using prim-
ers F13/F14 and R13/R14, while the second PCR reaction was 
performed using primers F22/R2 [26]. Cycling conditions for 
the first and second rounds of nested PCR were 94°C for 5 min-
utes, 35 cycles each consisting of 94°C for 30 seconds, 52°C for 
40 seconds, and 72°C for 1 minute and then 1 cycle of 72°C for 
10 minutes. Final amplification products were sent for sequenc-
ing to Macrogen USA (Rockville, Maryland). Sequencing was 
performed using primers F22/R2. Sequencing data were aligned 
and trimmed using the bioinformatics software Geneious R9.1 
[27]. Genogroups and genotypes were assigned using BLAST 
and constructing phylogenetic trees as previously described 
[22], including the sequences cited by Oka et al [28], and using 
maximum likelihood and a 2000 bootstrap performed using 
Geneious R9.1.
Statistical Analyses
Associations were tested using logistic regression models 
with generalized estimating equations to account for repeated 
measures in the same individuals. The attributable fraction of 
sapovirus infection was estimated based on the comparison 
of sapovirus prevalence in diarrheal and nondiarrheal stool 
samples [29]. Median Cq values of sapovirus in diarrheal and 
nondiarrheal stool samples were compared using the Mann-
Whitney U test. Cumulative incidence rates of sapovirus infec-
tion and symptomatic sapovirus infections were estimated by 
Kaplan-Meier survival analyses. To assess the associations of 
specific genogroups of sapovirus infection and diarrhea, the 
odds ratio (OR) was calculated for each genogroup and gen-
otype. The shedding period was estimated as described above 
and compared by genogroup using the Mann-Whitney U test or 
the Kruskal-Wallis test. A P value <.05 was considered statisti-
cally significant.
RESULTS
Sapovirus Infection
Sapovirus was detected in 192 of 1669 samples, 13.5% (118/877) 
of diarrheal stool samples and 9.7% (73/748) of nondiarrheal 
stool samples (P  =  .008). If symptom data were incomplete 
7 days before or after stool sampling, the data were not included 
in the analysis of the association between sapovirus infection 
and diarrhea (n = 44). The prevalence of sapovirus in diarrheal 
stool samples was significantly higher during the second year of 
life compared to the first: 21.0% and 5.8%, respectively (P < .001; 
Figure 1). Overall, the attributable fraction was 0.2% and 7.9% 
in the first and second years of life, respectively. Median Cq val-
ues of RT-qPCR in diarrheal samples were lower than in nondi-
arrheal samples (34.1 vs 35.6, P = .017, respectively).
Based on 192 positive cohort samples, 167 sapovirus infec-
tions were identified in 82 children. By testing the 440 samples 
to determine the duration of shedding, 8 additional sapovirus 
infections were identified. Therefore, 175 sapovirus infections 
were identified in 82 children, comprising 97 symptomatic, 68 
asymptomatic, and 10 infections classified as undefined.
Of 118 diarrheal samples positive for sapovirus, 111 were 
tested for norovirus and 106 were tested for rotavirus. The 
proportion of sapovirus diarrheal samples with coinfection 
with norovirus GI, GII, or rotavirus were 12.6% (14/111), 1.8% 
(2/111), and 3.6% (4/106), respectively, corresponding to 15% 
(15/97) of sapovirus symptomatic infections (coinfection with 
norovirus GI [n  =  2], norovirus GII [n  =  10], and rotavirus 
[n = 3]).
The incidence of sapovirus infection and diarrhea was 7.8 
(95% confidence interval [CI], 6.7–9.0) and 4.3 (CI, 3.5–5.3) 
per 100 child-months, respectively. The incidence of sapovirus 
infection was higher among children aged 12–24 months (11.1 
[CI, 9.1–13.1] per 100 child-months) compared to children aged 
<12 months (4.3 [CI, 3.2–5.7] per 100 child-months; P < .001).
Overall, 82 of the 100 children in our cohort had at least 
1 sapovirus infection during the 2-year follow-up, while 59 
experienced 2 or more sapovirus infections (Figure  2A). 
Furthermore, 64 children had at least 1 and 22 had 2 or more 
sapovirus symptomatic infections (Figure 2B).
Genogroup and Genotype Relation to Diarrhea
Of 175 infections, we successfully genotyped 112 (64%) infec-
tions in 66 children. For 1 other sample, its genogroup (GII) was 
defined but not its genotype. All 4 sapovirus genogroups that 
infect humans were detected. Genotyping was more successful 
in samples with higher viral loads, that is, 91% in samples with 
Cq <30 vs 50% in samples with Cq ≥30 (50%; P < .001).
Figure 1. Prevalence of sapovirus in diarrheal and nondiarrheal stool samples 
by age group. Prevalences were based on cross-sectional analysis of sapovirus 
detected by reverse transcription real-time polymerase chain reaction in 877 diar-
rheal and 748 nondiarrheal stool samples. Forty-four nondiarrheal samples, which 
were missing symptom data within 7 days from the sampling date, were excluded.
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The most frequently detected genogroup from 113 infections 
was GI (52/113, 46.0%), followed by GII (44/113, 38.9%), GIV 
(9/113, 8.0%), and GV (8/113, 7.1%). Among 113 infections 
with genogroup information, 69 were symptomatic, 36 were 
asymptomatic, and 8 were undefined. Significantly, GI viruses 
were found more frequently in symptomatic infections (38/69, 
55.1%) than in asymptomatic infections (10/36, 27.8%; OR, 3.1 
[CI, 1.3–7.4]; P  =  .011; Figure  3). GIV viruses were found in 
6 (8.7%) of 69 symptomatic infections and in 2 (5.4%) of 36 
asymptomatic infections (OR, 1.9 [CI, 0.4–8.9]; P = .396). GV 
viruses were found only in symptomatic infections. In contrast, 
GII viruses were less common in symptomatic (18/69, 26.1%) 
than in asymptomatic infections (24/36, 64.7%; OR, 0.2 [CI, 
0.1–0.5]; P < .001). A significant difference in median Cq values 
between symptomatic and asymptomatic samples was detected 
among those with GI viruses (P = .037), but not in samples with 
GII viruses (P = .383).
Fourteen of 19 known genotypes [28] were identified in 112 
samples (Supplementary Table S1). There was no dominant 
genotype over the 2 years of follow-up (Supplementary Figure 
S1). GI.1 (28/112, 25.0%) was the most frequently reported 
genotype, followed by GI.2 (13/112, 11.6%) and GII.1 (13/112, 
11.6%). Viruses with genotype GI.1, GI.2, GI.6, and GII.1 were 
more frequent in symptomatic than asymptomatic infections, 
albeit not significantly so (Figure 3).
Duration of Sapovirus Shedding
A total of 440 weekly collected stool samples from 61 sapovirus 
infections in 47 children were tested to determine the duration 
of viral shedding (Supplementary Figure S2). The median dur-
ation of sapovirus shedding was 18.5 days (interquartile range 
[IQR], 12.5–23.5) with a range of 5.5–41.5 days. The index sam-
ples corresponded to 38 symptomatic, 17 asymptomatic, and 6 
undefined infections. There was no difference in the duration 
of sapovirus shedding between symptomatic and asymptom-
atic infections (n = 38, median = 16 days [IQR, 11.5–21.5] vs 
n  =  17, median  =  20.5  days [IQR, 12.0–23.5]; P  =  .357). The 
median shedding periods were 16.5 and 18.5 days for GI and 
GII viruses, respectively (Figure  4). There was no significant 
difference in the median shedding time among the 4 geno-
groups (P = .158) even after adjusting for symptomatic status.
Reinfection
Of the 100 children, 23 had 1 infection and 59 had more than 1 
infection (Figure 2A). Of those 59, 152 infections were detected. 
Genogroup and genotypes were determined in 99 (65%) and 98 
samples (64%), respectively (Supplementary Table S2). We were able 
to compare 81 genotypes in 35 children with multiple infections. 
Figure 3. Proportion (%) of sapovirus genotypes detected by symptomatic and 
asymptomatic infection. Proportions (%) were based on the number of sapovirus 
infections whose genotypes were identified. Abbreviations: GI, genogroup I; GII, 
genogroup II; GIV, genogroup IV; GV, genogroup V.
Figure 2. Cumulative incidence of first and subsequent sapovirus infections (A) and sapovirus-associated diarrhea (B) in a birth cohort of 100 children. A, Survival curves 
show cumulative incidence of first through fifth sapovirus infection during the first 2 years of life. B, Curves show the cumulative incidence of the first through fifth infection 
of sapovirus-associated diarrhea. Of the 100 children, 23 had 1 sapovirus infection and 59 had more than 1 infection (34 had 2, 20 had 3, 3 had 4, 1 had 5, and 1 had 6).
1862 • CID 2018:66 (15 June) • Sánchez et al
Reinfection with the same genogroup was found in 51% (18/35) of 
those children (GI = 10 and GII = 8). Only 3 children had repeated 
infections with the same genotype of GI.1, which had >99% of iden-
tity of the nucleotide sequence, in the partial capsid region.
DISCUSSION
To our knowledge, this is the first birth cohort study done prior 
to rotavirus vaccine implementation to evaluate the epidemi-
ology of sapovirus infection in a low- to middle-income country. 
In this cohort, sapovirus, followed by norovirus as the next most 
common, was associated with both asymptomatic and sympto-
matic enteric viral infection during the first 2 years of life. Using 
RT-qPCR, the proportion of children who experienced at least 
1 sapovirus symptomatic infection was similar (64%) to that for 
a norovirus infection (71%) [23]. More than half of the children 
experienced sapovirus reinfection. Reinfection with the same 
genogroup was common but was rare with the same genotype.
In contrast to norovirus infection, which occurs frequently 
after an infant reaches age 6 months [23], sapovirus infections 
were generally delayed until the second year of life. Cumulative 
incidence of the first sapovirus infection was approximately 
half that of norovirus during the first year of life. This finding is 
concordant with previous studies conducted in Nicaragua and 
Japan [3, 30, 31].
Among previous community-based studies with active sur-
veillance, in Nicaragua GI, GII, and GIV viruses were reported 
using the same primers for VP1 region; in Brazil GI and GII were 
reported using polymerase region [3, 21]. In our study, sapovi-
rus was genetically highly diverse. All 4 human genogroups and 
14 of the 19 known genotypes that affect humans were iden-
tified. This diversity was higher than that reported in hospital 
settings in Vietnam and Bangladesh using primers for a similar 
region of VP1 [32, 33] and in the United States and India using 
the same primers [19, 20].
In our study, slightly more GI viruses than GII viruses 
were detected, which is similar to findings in a recent com-
munity-based study in Nicaragua [3]. GI viruses were more 
frequently detected than other genogroups in symptomatic 
infections, suggesting that GI viruses may be more pathogenic.
Reinfection of sapovirus has been reported in only a small 
number of cases from 1 clinic-based study in Japan [34]. A study 
that used antisera raised in animals showed limited cross-re-
activity between GI.1 and GI.5 viruses, even within the same 
genogroup [35]. Our study also demonstrated that the repeated 
infection of different genotypes in the same genogroup was 
frequent and that repeated infection by the same genotype was 
rare. Although greater sample size will be necessary to demon-
strate genotype-specific and/or cross immunity in each com-
bination of genotypes, this area of research will be particularly 
important for sapovirus vaccine development.
Our finding of a median shedding duration of 18.5 days for 
sapovirus was similar to the 15 days identified in older children 
and adults in Japan [17]. The median duration for norovirus GII 
was nearly twice as long (35 days) in the same population [23]. 
This difference suggests that the immune response to sapovirus 
may be more effective in limiting shedding compared to noro-
virus or that norovirus is more pathogenic than sapovirus. The 
difference in sensitivity of diagnostic methods must be taken 
into account. Our detection limit was similar for both sapovirus 
and norovirus, yet cDNA was used for detection of sapovirus 
while RNA was used for norovirus.
In this study, we were able to identify genotypes in more than 
60% of sapovirus-positive samples. High viral loads in a spec-
imen were important for obtaining sequences for genotyping.
Study limitations include the relatively small number of chil-
dren sampled (Supplementary Table S3) and the long 3-month 
interval for nondiarrheal stool sampling due to logistic limita-
tions. Therefore, the cumulative incidence of sapovirus may be 
underestimated. In addition, genotyping was based on a partial 
region of the VP1 gene, and not all genotypes were determined 
among sapovirus-positive samples. Therefore, recombinant 
strains or variants within the same genotypes were not evalu-
ated during analysis of repeated infections.
In summary, sapovirus frequently caused infection and 
diarrhea in young children, even prior to the implementation 
of a rotavirus vaccine, which may increase the relative impor-
tance of sapovirus as a diarrheal pathogen. Findings from this 
study as well as the study on norovirus from the same popula-
tion strongly suggest the need for a triple vaccine that targets 
rotavirus, norovirus, and sapovirus to prevent diarrhea among 
children.
Figure 4. Duration of sapovirus shedding by reverse transcription real-time poly-
merase chain reaction in 61 infections. Sixty-one sapovirus infections in 47 children 
were tested to determine the duration of viral shedding. The boxes represent the 
25th percentile, median, and 75th percentile, and the whiskers show the minimum 
and maximum value of the duration of shedding in days. For 2 infections for which 
the child’s last available specimen was positive, we estimated the duration of shed-
ding based on the date of the last positive sample (28.5 days and 41.5 days). There 
were 8 infections with a shedding period of 30 days or longer, 2 of which were 
symptomatic. Abbreviations: GI, genogroup I; GII, genogroup II; GIV, genogroup IV; 
GV, genogroup V.
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Supplementary Data
Supplementary materials are available at Clinical Infectious Diseases online. 
Consisting of data provided by the authors to benefit the reader, the posted 
materials are not copyedited and are the sole responsibility of the authors, 
so questions or comments should be addressed to the corresponding author.
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